Australia vs Uruguay: The number of people with susceptibility test result for rifampicin
Australia
597
in 2021
Uruguay
510
in 2021
Australia rank
76th
Uruguay rank
78th
The number of people with susceptibility test result for rifampicin over time
- Australia
- Uruguay
How they compare
Australia currently reports 597 against 510 in Uruguay, a difference of 87.
That makes Australia's figure about 1.2 times Uruguay's.
Across all 5 years both countries report, Australia has been ahead every year.
Australia ranks 76th and Uruguay ranks 78th of 155 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 702.67 | 508 | 194.67 | Australia |
| 2020s | 666 | 493 | 173 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Australia or Uruguay?
- Australia, at 597 against 510 in Uruguay as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Australia and Uruguay?
- 87, with Australia ahead.
- How many years of comparable data are there for Australia and Uruguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Australia and Uruguay rank globally for the number of people with susceptibility test result for rifampicin?
- Australia ranks 76th and Uruguay ranks 78th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.